Compliance checklist

6515--Sup - 644-27-1-101-0004 Ganglioside GM1-SHP 25MG · 36C262-27-Q-0026. 15 requirement sentences found in the notice and 1 attachment: every "shall", "must" and "required", quoted as written and sorted into submission requirements (1) and performance / contract clauses (14). Nothing is generated.

Pro

The full checklist is a Pro feature

15 requirement sentences on this RFP. Pro shows every one, grouped by section, with a CSV export, for $39/mo. Below is a preview.

Submission requirements · 1

RFI 36C26227Q0026 GANGLIOSIDE GM1.pdf · CHARACTERISTICS/SOW? · 1

Identify the country of origin of each product and indicate whether the product qualifies as a U.S.-made or designated-country end product in accordance with the Trade Agreements Act Sources Sought Notice Responses to this notice shall be submitted via email to wilbert.parks@va.gov. (also in notice)

Performance / contract clauses · 14

Notice · 2

The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required.
Responses must be received no later than Friday, October 9, 2024 by 4:00 PM EST.

RFI 36C26227Q0026 GANGLIOSIDE GM1.pdf · SALIENT CHARACTERISTICS · 2

Ganglioside GM1 must be sourced from ovine brain. 2.
Ganglioside GM1 must have a purity greater than 99%. 3.

Extracted from the notice text and attachments as published. The solicitation governs; read Sections L and M in full before you submit.